Intolerance to Multiple P2Y12 Inhibitors Following Percutaneous Coronary Intervention
| Autor: | Kinan Kassar, Vijaya Sanikommu, Deanna Huffman, Indu Poornima, Mina Shnoda |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
clopidogrel hypersensitivity
medicine.medical_specialty Aspirin p2y12 inhibitors Prasugrel multiple drug intolerance business.industry medicine.medical_treatment percutaneous coronary intervention General Engineering Cardiology Percutaneous coronary intervention Stent Clopidogrel P2Y12 medicine.anatomical_structure Internal medicine medicine cardiovascular diseases business Ticagrelor medicine.drug Artery |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | Dual antiplatelet therapy (DAPT), defined as administration of a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) and aspirin, is recommended after percutaneous coronary intervention. We describe a case of a 50-year-old gentleman with intolerance to the three previously mentioned P2Y12 inhibitors following the placement of a drug-eluting stent to the left anterior descending artery. To our knowledge, based on a thorough review of the literature, this is the second case reporting a similar medical dilemma. We have discussed the multidisciplinary approach implemented to overcome this clinical challenge, which involved the use of clopidogrel with simultaneous administration of a six-day course of oral steroids. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|